Fulgent Genetics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $71,743 | $71,028 | $64,485 | $70,505 |
Gross Profit | 26,771 | 24,501 | 20,114 | 23,271 |
EBITDA | -17,079 | -12,753 | -15,135 | -26,954 |
EBIT | -22,999 | -18,906 | -21,798 | -33,487 |
Net Income | -14,648 | -8,710 | -13,462 | -128,149 |
Net Change In Cash | 71,743 | 71,028 | 64,485 | 70,505 |
Free Cash Flow | -35,046 | -8,659 | 3,210 | 11,827 |
Cash | 58,042 | 65,111 | 54,677 | 97,473 |
Basic Shares | 30,416 | 30,098 | 29,769 | 29,771 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $289,213 | $618,968 | $992,584 | $421,712 |
Gross Profit | 104,456 | 366,901 | 777,051 | 331,905 |
EBITDA | -46,552 | 221,585 | 106,047 | 293,120 |
EBIT | -72,695 | 184,675 | 104,339 | 290,158 |
Net Income | -167,825 | 143,403 | 104,339 | 214,310 |
Net Change In Cash | 289,213 | 618,968 | 992,584 | 421,712 |
Cost of Revenue | 77,434 | 75,441 | ||
Free Cash Flow | 4,796 | 234,745 | 514,733 | 104,118 |
Cash | 97,473 | 79,506 | 164,894 | 87,426 |
Basic Shares | 29,784 | 30,964 | 30,976 | 24,056 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | $0.31 |
2024-06-30 | $0.15 |
2024-03-31 | -$0.01 |
2023-12-31 | $0.28 |
